β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis

Background: Evidence remains inconsistent regarding the potential influence of β-blocker (BB) use on clinical outcomes in women with breast cancer. We aimed to evaluate the association between BB and prognosis of breast cancer in an updated meta-analysis. Methods: Follow-up studies comparing the cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chaoran, Li, Tian, Tang, Runwei, Yuan, Shuai, Zhang, Weihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303345/
https://www.ncbi.nlm.nih.gov/pubmed/32436935
http://dx.doi.org/10.1042/BSR20200721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303345/
https://www.ncbi.nlm.nih.gov/pubmed/32436935
http://dx.doi.org/10.1042/BSR20200721

Ejemplares similares